Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
In Vitro Diagnostics Business Outlook 2024, with Top Company Briefs for Immucor, Luminex/Diasorin, Caredx & Thermo Fisher Scientific | ||
By: PR Newswire Association LLC. - 07 Feb 2024 | Back to overview list |
|
DUBLIN, Feb. 7, 2024 /PRNewswire/ -- The "In Vitro Diagnostics Business Outlook 2024" report has been added to ResearchAndMarkets.com's offering. The latest edition of the In Vitro Diagnostics Business Outlook offers critical data and analyses for stakeholders within the healthcare industry. This comprehensive publication delivers unparalleled market intelligence, presenting a multi-dimensional view of the in vitro diagnostics (IVD) sector with a spotlight on emerging trends, growth potential, and competitive dynamics through 2024.
This key resource aids businesses in making informed decisions by offering a thorough understanding of the IVD landscape - an industry imperative for healthcare strategists, product developers, investors, and market analysts. Market Dynamics: An In-Depth Focus Emerging Trends and Innovations: Key Topics Covered: Market Analysis: Molecular HLA/Transplant Testing
Executive News Briefing
Financial Highlights: Agilent and Hologic
Diagnostic Market Mergers, Acquisitions, and Partnership Deals
Broad-based Company Announcements
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/e568q5 About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Media Contact: Research and Markets For E.S.T Office Hours Call +1-917-300-0470 U.S. Fax: 646-607-1907 Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/in-vitro-diagnostics-business-outlook-2024-with-top-company-briefs-for-immucor-luminexdiasorin-caredx--thermo-fisher-scientific-302056407.html SOURCE Research and Markets |
||
|
||
Copyright 2024 PR Newswire Association LLC. | Back to overview list |